American Healthcare REIT, Inc. (AHR) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$49.60
Price Target
$56.75
Target Range
$55.00 — $60.00
Analyst Rating
Buy
Forward P/E66.0x
Trailing P/E118.1x
Forward PEG—
Implied Growth+349.4%
Median Target$56.00
Analyst Spread8.8%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$55
+10.9%
Consensus
$57
+14.4%
Bull Case
$60
+21.0%
AHR Price Target Analysis
Updated May 8, 2026As of May 8, 2026, American Healthcare REIT, Inc. (AHR) has a Wall Street consensus price target of $56.75, based on estimates from 11 covering analysts. With the stock currently trading at $49.60, this represents a potential upside of +14.4%. The company has a market capitalization of $9.52B.
Analyst price targets range from a low of $55.00 to a high of $60.00, representing a 9% spread in expectations. The median target of $56.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 10 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, AHR trades at a trailing P/E of 118.1x and forward P/E of 66.0x. Analysts expect EPS to grow +349.4% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Real Estate stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+3.5%
Avg Forward P/E112.8x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 WELLWelltower Inc. | $149.2B | $213.02 | $226.50 | +6.3% | Buy | 78.4x | 34 |
 VTRVentas, Inc. | $41.1B | $86.54 | $90.80 | +4.9% | Buy | 118.0x | 32 |
 HRHealthcare Realty Trust Incorporated | $7.0B | $20.00 | $19.33 | -3.3% | Hold | — | 29 |
 DOCHealthpeak Properties, Inc. | $13.7B | $19.66 | $17.86 | -9.2% | Buy | 100.9x | 40 |
 OHIOmega Healthcare Investors, Inc. | $13.7B | $46.13 | $49.14 | +6.5% | Hold | 23.4x | 28 |
 SBRASabra Health Care REIT, Inc. | $5.2B | $20.58 | $21.20 | +3.0% | Hold | 29.8x | 29 |
 LTCLTC Properties, Inc. | $1.9B | $38.64 | $36.00 | -6.8% | Hold | 19.9x | 22 |
 CTRECareTrust REIT, Inc. | $8.8B | $39.51 | $42.50 | +7.6% | Buy | 26.6x | 19 |
 NHINational Health Investors, Inc. | $3.6B | $75.06 | $85.40 | +13.8% | Hold | 22.2x | 18 |
 GMREGlobal Medical REIT Inc. | $94M | $35.74 | $40.00 | +11.9% | Buy | 595.7x | 22 |
Upside Potential Comparison
NHIGMRECTREOHIWELLVTRSBRAHRFull AHR Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See AHR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AHR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AHR vs WELL
Side-by-side business, growth, and profitability comparison vs Welltower Inc..
Start ComparisonAHR — Frequently Asked Questions
Quick answers to the most common questions about buying AHR stock.
What is the AHR stock price target for 2026?
American Healthcare REIT, Inc. (AHR) has a consensus 12-month price target of $56.75, implying 14.4% upside from $49.6. The 11 analysts covering AHR see moderate appreciation potential.
Is AHR a buy, sell, or hold?
AHR has a consensus rating of "Buy" based on 11 Wall Street analysts. The rating breakdown is predominantly bullish, with 10 Buy/Strong Buy ratings. The consensus 12-month price target of $56.75 implies 14.4% upside from current levels.
Is AHR stock overvalued or undervalued?
At a forward P/E of 65.975x, AHR trades at a premium valuation. The consensus price target of $56.75 (14.4% upside) suggests analysts still see growth justifying the multiple.
How high can AHR stock go?
The most bullish Wall Street analyst has a price target of $60 for AHR, while the most conservative target is $55. The consensus of $56.75 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover AHR stock?
AHR is moderately covered, with 11 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 10 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the AHR stock forecast?
The 12-month AHR stock forecast based on 11 Wall Street analysts shows a consensus price target of $56.75, with estimates ranging from $55 (bear case) to $60 (bull case). The median consensus rating is "Buy".
What is AHR's forward P/E ratio?
AHR trades at a forward P/E ratio of 66.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 118.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy AHR stock?
Wall Street analysts are optimistic on AHR, with a "Buy" consensus rating and $56.75 price target (14.4% upside). 10 of 11 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do AHR price targets vary so much?
AHR analyst price targets range from $55 to $60, a 9% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $56.75 consensus represents the middle ground.